Kopion Asset Management LLC Cuts Stake in Simulations Plus, Inc. $SLP

Kopion Asset Management LLC reduced its position in Simulations Plus, Inc. (NASDAQ:SLP) by 27.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 134,388 shares of the technology company’s stock after selling 51,006 shares during the quarter. Simulations Plus accounts for approximately 1.8% of Kopion Asset Management LLC’s investment portfolio, making the stock its 18th largest holding. Kopion Asset Management LLC owned approximately 0.67% of Simulations Plus worth $2,450,000 at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in SLP. Raymond James Financial Inc. purchased a new position in Simulations Plus during the 2nd quarter valued at about $25,000. Quarry LP purchased a new stake in shares of Simulations Plus in the 3rd quarter worth approximately $28,000. CWM LLC lifted its position in shares of Simulations Plus by 3,729.1% in the 3rd quarter. CWM LLC now owns 2,106 shares of the technology company’s stock worth $32,000 after purchasing an additional 2,051 shares during the period. Farther Finance Advisors LLC bought a new position in shares of Simulations Plus during the third quarter valued at approximately $40,000. Finally, US Bancorp DE increased its holdings in Simulations Plus by 32.5% during the third quarter. US Bancorp DE now owns 6,167 shares of the technology company’s stock valued at $93,000 after buying an additional 1,513 shares during the period. 78.08% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on SLP. Citigroup reissued a “market perform” rating on shares of Simulations Plus in a research note on Tuesday, January 6th. Zacks Research downgraded Simulations Plus from a “strong-buy” rating to a “hold” rating in a report on Monday, February 2nd. TD Cowen reissued a “hold” rating on shares of Simulations Plus in a research report on Thursday, January 8th. Finally, BTIG Research cut Simulations Plus from a “buy” rating to a “neutral” rating in a research note on Thursday, December 18th. Three investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $25.00.

Simulations Plus Stock Up 0.7%

Shares of SLP opened at $11.71 on Friday. The company has a 50 day moving average of $14.91 and a two-hundred day moving average of $16.25. Simulations Plus, Inc. has a twelve month low of $11.16 and a twelve month high of $36.45. The company has a market cap of $235.92 million, a price-to-earnings ratio of -3.66 and a beta of 1.17.

Simulations Plus (NASDAQ:SLP) last issued its quarterly earnings results on Thursday, January 8th. The technology company reported $0.13 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.05). The business had revenue of $18.42 million for the quarter, compared to analyst estimates of $18.05 million. Simulations Plus had a positive return on equity of 14.02% and a negative net margin of 81.66%.During the same period in the previous year, the company posted $0.17 earnings per share. On average, sell-side analysts expect that Simulations Plus, Inc. will post 1.09 EPS for the current year.

Simulations Plus Profile

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.